| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | -0.13 | 0.07 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.065 | 0.07 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.07 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.07 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.07 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.057 | 0.09 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.09 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | -0.077 | 0.09 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | -0.062 | 0.1 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.1 |